Next Article in Journal
The MCIB Model: A Novel Theory for Describing the Spatial Heterogeneity of the Tumor Microenvironment
Previous Article in Journal
Genomic and Transcriptomic Profile of HNF1A-Mutated Liver Adenomas Highlights Molecular Signature and Potential Therapeutic Implications
Previous Article in Special Issue
The Bifunctional Dimer Caffeine-Indan Attenuates α-Synuclein Misfolding, Neurodegeneration and Behavioral Deficits after Chronic Stimulation of Adenosine A1 Receptors
 
 
Review
Peer-Review Record

Hypoxia Pathways in Parkinson’s Disease: From Pathogenesis to Therapeutic Targets

Int. J. Mol. Sci. 2024, 25(19), 10484; https://doi.org/10.3390/ijms251910484 (registering DOI)
by Yuanyuan Gao 1, Jiarui Zhang 1, Tuoxian Tang 2 and Zhenjiang Liu 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2024, 25(19), 10484; https://doi.org/10.3390/ijms251910484 (registering DOI)
Submission received: 5 September 2024 / Revised: 23 September 2024 / Accepted: 27 September 2024 / Published: 29 September 2024

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

The manuscript (IJMS-3219983) titled “Hypoxia Pathways in Parkinson’s disease: from pathogenesis to therapeutic targets" by Gao et al. is a fascinating review that analyzed hypoxia as a potential factor in the development of Parkinson's disease.

Although the problem of the participation of hypoxia in the pathogenesis of PD is controversial, the collection of all the experimental data to date and their obvious presentation enriched with appropriate graphics has a very high cognitive value.

Considering the problem of hypoxia in the development of new, more effective PD therapies may also have practical significance in the clinic. Hence, I believe that this work deserves publication.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Comments and Suggestions for Authors

Gao et al analyze the significance of hypoxia pathways in Parkinson's disease (PD). I have the following comments regarding this work:

1. The introduction lacks a description of clinical manifestation of Parkinson's disease indicating its motor and non-motor symptoms. This could possibly highlight the link between clinical and biochemical grounds - Ref.

Significance of dysautonomia in Parkinson's Disease and atypical parkinsonisms. Neurol Neurochir Pol. 2024;58(2):147-149. doi: 10.5603/pjnns.98678. Epub 2024 Mar 19. PMID: 38501557.

Diffusion tensor metrics, motor and non-motor symptoms in de novo Parkinson's disease. Neuroradiology. 2024 Aug 27. doi: 10.1007/s00234-024-03452-6. Epub ahead of print. PMID: 39190159.

2. The aspect of hypoxia could be more emphasized in the context of neurodegeneration, it would be interesting to provide a perspective on its significance in atypical parkinsonisms, where synucleinopathies and tauopathies can be mentioned.

3. The issue presented could be stressed in the context of future perspectives and possible therapies.

 

  • justify more extensively the choice for PD in the context of hypoxia analysis
  • provide an overview on the methodological search in the context of literature
  • provide an additional paragraph on most recent advances in the context of hypoxia in Parkinson’s Disease 
  • due to the multiple theories regarding the pathogenesis of PD e.g inflammatory, it would be interesting to provide an elaboration on the issue, this could be additionally discussed in the context of related disorders e.g. PSP and MSA

 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

Comments and Suggestions for Authors

I do not have further comments.

Back to TopTop